Buys | $0 | 0 | 0 |
Sells | $49,750,591 | 20 | 100 |
Kiely John | director | 0 | $0 | 1 | $142,946 | $-142,946 |
Autor Deborah M. | director | 0 | $0 | 4 | $590,180 | $-590,180 |
Alva Emily Peterson | director | 0 | $0 | 1 | $712,000 | $-712,000 |
Shah Nikita | Executive Vice President | 0 | $0 | 1 | $775,000 | $-775,000 |
Konidaris Tasos | Executive Vice President & CFO | 0 | $0 | 1 | $891,000 | $-891,000 |
Daly Jason B. | SVP, Chief Legal Officer | 0 | $0 | 4 | $1.28M | $-1.28M |
BOYER ANDREW S | Executive Vice President | 0 | $0 | 3 | $1.6M | $-1.6M |
Patel Gautam | director | 0 | $0 | 4 | $2M | $-2M |
Patel Tushar Bhikhubhai | 10 percent owner | 0 | $0 | 1 | $41.75M | $-41.75M |
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in …
Over the last 12 months, insiders at Amneal Pharmaceuticals, Inc. have bought $0 and sold $49.75M worth of Amneal Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Amneal Pharmaceuticals, Inc. have bought $802,275 and sold $11.84M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 50,000 shares for transaction amount of $210,500 was made by Patel Gautam (director) on 2021‑12‑17.
2025-03-14 | Sale | Patel Tushar Bhikhubhai | 10 percent owner | 5M 1.0326% | $8.35 | $41.75M | -1.49% | |
2025-03-06 | Sale | Daly Jason B. | EVP, Chief Legal Officer | 46,936 0.0101% | $8.73 | $409,751 | -0.23% | |
2025-03-05 | Sale | Konidaris Tasos | Executive Vice President & CFO | 100,000 0.0214% | $8.91 | $891,000 | -2.23% | |
2025-03-05 | Sale | BOYER ANDREW S | Executive Vice President | 125,000 0.0267% | $8.89 | $1.11M | -2.23% | |
2025-03-05 | Sale | Alva Emily Peterson | director | 80,000 0.0171% | $8.90 | $712,000 | -2.23% | |
2025-03-05 | Sale | Daly Jason B. | EVP, Chief Legal Officer | 43,064 0.0092% | $8.88 | $382,408 | -2.23% | |
2025-03-03 | Sale | Patel Gautam | director | 80,000 0.0176% | $8.90 | $712,000 | +0.23% | |
2025-02-03 | Sale | Patel Gautam | director | 80,000 0.0171% | $8.14 | $651,200 | +3.61% | |
2025-01-08 | Sale | Patel Gautam | director | 62,590 0.0135% | $8.01 | $501,346 | +5.15% | |
2025-01-02 | Sale | Patel Gautam | director | 17,410 0.0039% | $8.01 | $139,454 | +7.09% | |
2024-11-22 | Sale | Kiely John | director | 17,058 0.0037% | $8.38 | $142,946 | -2.03% | |
2024-11-22 | Sale | Autor Deborah M. | director | 33,229 0.0072% | $8.34 | $277,130 | -2.03% | |
2024-11-21 | Sale | Autor Deborah M. | director | 6,771 0.0015% | $8.41 | $56,944 | -1.02% | |
2024-11-21 | Sale | Daly Jason B. | SVP, Chief Legal Officer | 13,665 0.003% | $8.40 | $114,786 | -1.02% | |
2024-11-15 | Sale | Daly Jason B. | SVP, Chief Legal Officer | 43,657 0.0136% | $8.61 | $375,887 | -2.48% | |
2024-08-15 | Sale | BOYER ANDREW S | Executive Vice President | 40,225 0.0136% | $7.85 | $315,766 | +6.83% | |
2024-08-14 | Sale | BOYER ANDREW S | Executive Vice President | 22,486 0.0076% | $7.81 | $175,616 | +8.19% | |
2024-08-14 | Sale | Shah Nikita | Executive Vice President | 100,000 0.0335% | $7.75 | $775,000 | +8.19% | |
2024-05-17 | Sale | Autor Deborah M. | director | 23,447 0.0076% | $6.73 | $157,728 | +20.01% | |
2024-05-16 | Sale | Autor Deborah M. | director | 14,553 0.0047% | $6.76 | $98,378 | +21.19% |
Patel Gautam | director | 1808886 0.3915% | $15.79M | 3 | 4 | +0.6% |
BOYER ANDREW S | Executive Vice President | 290106 0.0628% | $2.53M | 2 | 4 | <0.0001% |
Kiely John | director | 267175 0.0578% | $2.33M | 1 | 1 | +5.19% |
Patel Chintu | Co-CEO | 512566 0.1109% | $4.47M | 6 | 0 | +5.05% |
Patel Chirag K. | President & Co-CEO | 512566 0.1109% | $4.47M | 6 | 0 | +5.05% |
$910,099,463 | 123 | 11.52% | $2.58B | |
$23,522,750 | 59 | -6.74% | $5.36B | |
$14,599,168 | 59 | 12.79% | $1.41B | |
$86,177,559 | 48 | 44.65% | $13.99B | |
$97,642,477 | 41 | -10.58% | $856.51M |
Increased Positions | 125 | +75.3% | 10M | +6.68% |
Decreased Positions | 66 | -39.76% | 26M | -18.29% |
New Positions | 41 | New | 2M | New |
Sold Out Positions | 25 | Sold Out | 3M | Sold Out |
Total Postitions | 225 | +35.54% | 126M | -11.61% |
Vanguard Group Inc | $129,867.00 | 4.79% | 14.84M | +218,025 | +1.49% | 2024-12-31 |
Blackrock, Inc. | $110,145.00 | 4.06% | 12.59M | +177,458 | +1.43% | 2024-12-31 |
Tpg Gp A, Llc | $107,877.00 | 3.98% | 12.33M | 0 | 0% | 2024-12-31 |
Rubric Capital Management Lp | $93,816.00 | 3.46% | 10.72M | 0 | 0% | 2024-12-31 |
Citadel Advisors Llc | $78,583.00 | 2.9% | 8.98M | +88,675 | +1% | 2024-12-31 |
Dimensional Fund Advisors Lp | $43,677.00 | 1.61% | 4.99M | +278,653 | +5.91% | 2024-12-31 |
Geode Capital Management, Llc | $33,366.00 | 1.23% | 3.81M | +26,536 | +0.7% | 2024-12-31 |
Neuberger Berman Group Llc | $32,924.00 | 1.21% | 3.76M | -24,918 | -0.66% | 2024-12-31 |
State Street Corp | $32,359.00 | 1.19% | 3.7M | +183,425 | +5.22% | 2024-12-31 |
Nantahala Capital Management, Llc | $32,073.00 | 1.18% | 3.67M | +995,586 | +37.29% | 2024-12-31 |